Alice Cortez

Alice Cortez

Auto-generated profile, based on publicly available information

Alice Cortez

University of Porto

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2018 in Medicine
Verified
Journal Article
Open access
MFMargarida Figueiredo-Braga
Margarida Figueiredo-Braga
CCCaleb Cornaby
Caleb Cornaby
ACAlice Cortez
Alice Cortez
MBMiguel Bernardes
Miguel Bernardes
GTGeorgina Terroso
Georgina Terroso
BPBrian Poole
Brian Poole
Depression and anxiety cause severe loss of quality of life for patients with systemic lupus erythematosus. The causes and factors that contribute to these psychological manifestations in lupus are difficult to disentangle. This study compared clinical, psychological, and demographic factors between lupus patients, depressed patients, and rheumatoid arthritis patients to discover lupus-specific contributors to depression. Lupus-specific manifestations of depression were also investigated. Physiological, clinical, and psychosocial data were collected from 77 patients. ELISA was used to measure cytokine levels. Univariate and Multivariate analyses were used to compare the patient populations and identify correlations between key physical and psychological indicators. The prevalence of depression in the SLE cohort was 6 times greater than the healthy control subjects. Pain, IL-6, and Pittsburgh Sleep Quality index values were all significantly higher in SLE patients compared with the healthy control group (P < .001, P = .038, and P = .005, respectively). Anxiety levels were significantly higher in SLE patients compared to healthy and RA control patients (P = .020 and .011, respectively). Serum IL-10 concentrations, relationship assessment scale, and fatigue severity scale values were found to be correlated with depression among the SLE patients (P = .036, P = .007, and P = .001, respectively). Relationship assessment and fatigue severity scale scores were found to be the best indicators of depression for the SLE patients (P = .042 and .028, respectively). Fatigue Severity, relationship satisfaction, and IL-10 concentrations are indicators of depression in lupus patients. Despite also suffering from the pain and disability that accompanies chronic autoimmune disease, the rheumatoid arthritis patients had less anxiety and better relationship scores.

29 April 2016 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
MMMarzieh Moeenfard
Marzieh Moeenfard
ACAlice Cortez
Alice Cortez
VMVera Machado
Vera Machado
Raquel CostaRaquel Costa
Raquel Costa
CLCarla Luís
Carla Luís
ASAlejandro Santos
Alejandro Santos

17 July 2018 in Journal of Immunology Research
Verified
Journal Article
Open access
MFMargarida Figueiredo-Braga
Margarida Figueiredo-Braga
CCCaleb Cornaby
Caleb Cornaby
ACAlice Cortez
Alice Cortez
MBMiguel Bernardes
Miguel Bernardes
GTGeorgina Terroso
Georgina Terroso
BPBrian Poole
Brian Poole
Purpose. Rheumatoid arthritis (RA) is an often debilitating autoinflammatory disease. Patients with rheumatoid arthritis are often troubled by co-occurring depression or other psychological manifestations. RA patients have a variety of treatment options available, including biologicals that inhibit cytokines or immune cells. If these cytokines influence the psychological symptoms, then the use of cytokine inhibitors should modulate these symptoms. Methods. A cohort of 209 individuals was recruited. This group included 82 RA patients, 22 healthy subjects, 32 depressed control subjects, and 73 subjects with systemic lupus erythematosus. Of the RA patients, 51% were on a biological therapeutic. ELISA was used to measure cytokine levels. A variety of psychological assessments were used to evaluate depression, anxiety, sleep, fatigue, and relationship status. Clinical values were obtained from medical records. Results. IL-10 concentration was associated with depressive symptoms in the RA patients, healthy controls, and the lupus patients. In the patients with primary depression, depressive symptoms were associated with IL-6 and TNF-alpha. In RA patients, Tocilizumab use was associated with decreased depressive symptoms. 14 RA patients who were not using biologicals began using them by a one-month follow-up. In these patients, there was no significant change to any value except for fatigue. Conclusions. A variety of both biological and social factors influences depressive symptoms in RA. IL-10 and IL-6 are likely to be involved, since IL-10 concentration was associated with depression and Tocilizumab decreased depressive symptoms in the RA patients. The roles of these cytokines are different in RA and lupus, as high IL-10 in RA is associated with increased depressive symptoms, but high IL-10 in the lupus patients is associated with decreased depression. IL-6 was also associated with depressive symptoms in the patients with primary depression. These results strongly indicate that disease activity, including cytokine levels, has a strong impact on depressive symptoms.

15 May 2017 in The Journal of Rheumatology
Verified
Journal Article
Closed access
PDF file
ICInês João Silva Chora
Inês João Silva Chora
EREloisa Romano
Eloisa Romano
Mirko ManettiMirko Manetti
Mirko Manetti
CMCelestina Mazzotta
Celestina Mazzotta
Raquel CostaRaquel Costa
Raquel Costa
MMMarco Matucci-Cerinic
Marco Matucci-Cerinic
Objective.: To investigate whether patients with a very early diagnosis of systemic sclerosis (VEDOSS) may already present circulating markers and in vitro signs of microvascular dysfunction.Methods.: Serum samples were obtained from 55 patients with systemic sclerosis (SSc), 25 patients with VEDOSS, and 55 matched healthy controls (HC). Serum levels of pan-vascular endothelial growth factor (VEGF) and soluble neuropilin-1 (sNRP-1) were measured by ELISA. Human dermal microvascular endothelial cells (H-MVEC) were cultured and stimulated with SSc, VEDOSS, and HC sera. Protein expression of NRP-1 was analyzed by Western blotting, cell proliferation by 5′-bromodeoxyuridine assay, migration capacity by wound-healing assay, and capillary-like tube formation by Matrigel assay.Results.: Serum levels of pan-VEGF were increased in patients with VEDOSS and SSc versus HC (p = 0.05 and p = 0.003, respectively). Serum levels of sNRP-1 were significantly reduced in patients with VEDOSS and SSc compared with controls (p = 0.012 and p = 0.027, respectively). NRP-1 expression was decreased in H-MVEC stimulated with VEDOSS sera (p < 0.001 vs HC). Proliferation was reduced in H-MVEC stimulated either with VEDOSS or SSc sera in comparison with HC sera (p = 0.015 and p = 0.043, respectively). Wound healing was compromised in H-MVEC stimulated with VEDOSS and SSc sera versus HC sera (p < 0.01 for both). Capillarogenesis was decreased in H-MVEC stimulated with VEDOSS sera (p < 0.01) and SSc sera (p < 0.001) compared with cells stimulated with HC sera.Conclusion.: Similar to patients with SSc, patients with VEDOSS already present biological signs of endothelial dysfunction. Our data demonstrate that VEDOSS sera significantly modify endothelial cell behavior and impair the angiogenic potential of the microvascular system.

19 January 2021 in British Journal of Nutrition
Verified
Journal Article
Open access
PDF file
CPCátia Pinheiro
Cátia Pinheiro
NMNara Xavier Moreira
Nara Xavier Moreira
PFPedro Ferreira
Pedro Ferreira
CCCláudia Matta Coelho
Cláudia Matta Coelho
JGJuliana Guimarães
Juliana Guimarães
Elisa KeatingElisa Keating
Elisa Keating
Lack of knowledge about iodine has been suggested as a risk factor for iodine deficiency in pregnant women but no studies have addressed this issue in Portugal. So, the aim of this study was to investigate iodine knowledge among Portuguese pregnant women and its association with iodine status. IoMum, a prospective observational study, included 485 pregnant women recruited at Centro Hospitalar e Universitário de S. João, Porto, between the 10th and 13th gestational weeks. Partial scores for knowledge on iodine importance, on iodine food sources or on iodised salt were obtained through the application of a structured questionnaire. Then, a total iodine knowledge score was calculated and grouped in low, medium and high knowledge categories. Urinary iodine concentration (UIC) was measured in spot urine samples by inductively coupled plasma mass spectrometry. 54% of pregnant women correctly recognized iodine as important to neurocognitive development, 32% were unable to identify any iodine rich food and 71% presented lack of knowledge regarding iodised salt. 61% of women had a medium total score of iodine knowledge. Knowledge on iodine importance during pregnancy was positively associated with iodine supplementation and also with UIC. Nevertheless, median UIC in women that correctly recognized the importance of iodine was below the cut-off for adequacy in pregnancy (150 µg/L). In conclusion, knowledge on iodine importance associated positively with iodine status. Despite this, recognizing iodine importance during pregnancy may not be sufficient to ensure iodine adequacy. Literacy promoting actions are urgently needed to improve iodine status in pregnancy.